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RISK FACTORS AND OUTCOME DIFFERENCES BETWEEN 
ISCHEMIC AND HEMORRHAGIC STROKE 
Ivica Bilic, Gordan Diamanja, Iva Lusic, Meri Matijaca and Kresimir Caljkusic 
University Department of Neurology, Split University Hospital Center, Split, Croatia 
SUMMARY - The aim of the study was to justify the hypothesis that risk factors do not differ 
between ischemic and hemorrhagic stroke. This retrospective study included 1066 stroke patients. 
The prevalence of risk factors and hospital-based survival were compared between patients with 
ischemic and hemorrhagic stroke. Data were retrieved from patient records. Statistical analysis was 
done by use of i-test and t-test for dependent samples. The group of hemorrhagic stroke con-
sisted of70 (47.9%) female and 76 (52.1%) male patients. The group ofischemic stroke included 450 
(48.9%) female and 470 (51.1%) male patients. Ischemic stroke patients had a higher prevalence of 
hypertension (79% vs. 72%), atherosclerotic diseases (50% vs. 34%) and atrial fibrillation (15.5% vs. 
4.2%), and were statistically significantly older (72.5±10.4 VS. 65.7±12.8) than those with hemor-
rhagic stroke, however, fatal outcome was more common in the latter (26% vs. 17%). In conclusion, 
data analysis pointed to differences between hemorrhagic and ischemic stroke according to both risk 
factors and stroke outcome. 
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Introduction 
Stroke is the second leading cause of mortality 
worldwide and remains the leading cause of adult 
physical disability. Almost 1 300 000 people die 
from cerebrovascular diseases in Europe every year. 
In 2007, some 6 million people died from stroke and 
millions suffer disabling sequels of stroke. The costs 
of stroke include medical care, rehabilitation and lost 
productivity of stroke survivors. It is measured in bil-
lions of euros every year. The costs in terms of pain 
and suffering of its victims and their families cannot 
be measured. Stroke is a highly heterogeneous disor-
der with distinct subtypes, each presenting specific 
clinical and epidemiological aspects!·2 Risk factors 
for stroke include systolic or diastolic hypertension, 
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diabetes, atrial fibrillation, hypercholesterolemia, cig-
arette smoking, heavy alcohol consumption, and oral 
contraceptive use. 
By definition, stroke produces neurologic deficits 
that persist for at least 24 hours. Stroke produces focal 
symptoms and signs that correlate with the area of the 
brain supplied by the affected blood vessel. 
Ischemic stroke has many causes with differ-
ent clinical presentations, risk factors, courses and 
outcomes3,4. The prognosis and management of isch-
emic stroke are directly related to the specific mecha-
nism of ischemic lesion. Comparison of functional 
outcome and survival and recurrence rates can allow 
clinicians to identify patients at a higher risk of stroke 
recurrence and death. Early classification of isch-
emic stroke subtype is of substantial practical clini-
cal value. The classification of ischemic stroke used in 
this study was The Oxfordshire Community Stroke 
Project (OCSP) classification, which defines four 
clinically identifiable subgroups of cerebral infarction: 
total anterior circulation infarction (TACI), partial 
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anterior circulation infarction (PACI), posterior cir-
culation infarction (POCI), and lacunar infarction 
(LACI). OCSP has the ability to predict the prog-
nosis and shows good correlation with the underly-
ing pathophysiology and imaging findings on cranial 
computed tomography'·6. 
There is another stroke classification system 
used in some recent stroke studies, and it is named 
TOAST (Trial ofORG 10172 in Acute Stroke Treat-
ment) classification, which denotes five diagnostic 
subgroups of ischemic stroke: large-artery atheroscle-
rosis, cardioembolism, small-vessel occlusion, i.e. la-
cunar, stroke of other determined etiology, and stroke 
of undetermined etiology. One argument against the 
use of this type of subclassification system is the dif-
ficulty of performing the necessary technical exami-
nations in all patients; so we decided to use OCSP in 
this particular survey. 
Hemorrhagic stroke was classified as intracerebral 
hematoma or subarachnoid hemorrhage. 
Correct classification of stroke subtypes in patients 
with acute stroke is crucial for early management and 
for predicting the prognosis7•s 
The objective of this hospital-based study was to 
evaluate outcomes of patients with stroke (according to 
risk factors and stroke type) treated at Split University 
Hospital Center during a one-year period. The hypoth-
esis was that ischemic and hemorrhagic strokes do not 
differ in outcome when risk factors are considered. 
Patients and Methods 
The study was retrospective and was conducted 
by three neurologists and two neurology residents. It 
included all patients treated for stroke at University 
Table 1. Stroke type and outcome analysis 
Department of Neurology, Split University Hospi-
tal Center, Split, Croatia, during a one-year period 
(2006). Stroke was defined according to the World 
Health Organization definition as "rapidly develop-
ing clinical signs of focal (or global) disturbance of 
cerebral function lasting for more than 24 hours (un-
less interrupted by surgery or death), with no apparent 
cause other than of vascular origin"9. 
The study included first ever stroke, recurrent 
stroke, all ischemic strokes, and all types of hemor-
rhagic stroke as mentioned above. Recurrent stroke 
was defined as a new neurological deficit fitting the 
definition of ischemic stroke, occurring after a period 
of unequivocal neurological stability or improvement 
lasting for ,,24 hours and not attributable to edema, 
mass effect, brain shift syndrome, or hemorrhagic 
transformation of the incident cerebral infarction. 
Medical chart of every stroke patient was surveyed 
for the following risk factors: sex, age, atherosclerotic 
disease, diabetes, hyperlipidemia, cigarette smoking, 
previous stroke, atrial fibrillation, and alcoholism, and 
for stroke outcome. The hospital-based study included 
1066 patients. 
Statistical analysis was performed using the Sta-
tistica 7.0 for Windows software, t-test for dependent 
samples and Pearson's xl-test. The level of significance 
was set at P<0.05. 
Results 
The study included 1066 stroke patients treated 
at University Department of Neurology, Split Uni-
versity Hospital Center, in 2006. Hemorrhagic and 
ischemic stroke are presented by subtypes in Table 1. 
There were 70 (47.6%) women and 76 (52.4%) men 
Outcome 




Lacunar stroke (LACI) 
Partial anterior circulation 
infarction (PACI) 




111/146 (76.0) 37 (25.3) 
35/146 (24.0) 3 (2.0) 
153/920 (16.6) 22 (2.4) 
109/920 (11.8) 16 (1.7) <0.001 
475/920 (51.6) 94 (10.2) 
183/920 (19.9) 24 (2.6) 
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Table 2. Risk foctor analysis 
Risk factor 
Sex (n~546; 51.1 %) Male 
(n~520; 48.9%) Female 
Mean± SD 
Age (yrs) Median 
Range 
H}1lertension (n~849; 80%) yes 
Atherosclerotic disease (n~525; 49%) yes 
H}1lerlipidemia (n~382; 36%) yes 
Atrial fibrillation (n~153; 14%) yes 
Diabetes (n~465; 44%) type 1 
type 2 
Smoking (n~179; 17%) yes 
Previous stroke (n~212; 20%) yes 
Alcohol consumption (n~197; 18%) yes 
Mean± SD 
Hospital stay (days) Median 
Range 
• x} - test; ** t - test 
Table 3. Risk factors according to stroke type and lethal 
outcome 
Risk factor Deceased 
Atherosclerosis 22/59 (37.3%) 
Smoking 5/34 (14.7%) 
Alcohol consumption 9/37 (24.3%) 
Hemorrhagic Atrial fibrillation 3/8 (37.5%) 
stroke Previous stroke 7/27 (25.9%) 
H}1lerlipidemia 9/44 (20.5%) 
Diabetes 17/62 (27.4%) 
Hypertension 37/127 (29.1%) 
Atherosclerosis 236/459 (51.4%) 
Smoking 17/142 (12.0%) 
Ischemic Alcohol consumption 17/158 (10.8%) 
stroke Atrial fibrillation 32/144 (22.2%) 
Previous stroke 34/182 (18.7%) 
H}1lerlipidemia 37/331(11.2%) 
Diabetes 77/398 (19.3%) 
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Stroke t}1le 
Hemorrhagic Ischemic 
(N~l46) (N~920) P 
76 470 0.753' 
70 450 
65.7±12.8 72.5±10.4 
68 74 ,0.001" 
28-93 35-95 
105 744 0.045' 
57 468 ,0.001' 
43 339 0.026' 
7 146 ,0.001' 
5 22 0.15' 
55 383 
34 145 0.11' 
26 186 0.195' 
36 161 0.27 
11.9±8.2 10.9±11.6 0.84" 
13 10 
1-39 1-31 
with hemorrhagic stroke, and 450 (48.9%) women and 
470 (51.1%) men with ischemic stroke. The mean age 
was 72.9±10.5 (range 33-95) years in female patients 
and 69.8±11.9 (range 25-94) years in male patients. 
Statistical analysis showed the women having suffered 
stroke to be significantly older than men (P,O.OOl). 
Risk factor analysis is presented in Table 2. 
Atherosclerosis was more common in patients suf-
fering from ischemic stroke than in those with hem-
orrhagic stroke. Atrial fibrillation and dyslipidemia 
were also more common as risk factors in ischemic 
than in hemorrhagic stroke. Patients with ischemic 
stroke were older than those with hemorrhagic stroke. 
Lethal outcome was more common in patients with 
hemorrhagic stroke, the difference being statisti-
cally significant (P~0.004). Table 3 shows differences 
in risk factors and lethal outcome between different 
types of stroke. 
Discussion 
Analysis and comparison of the data collected 
clearly showed the hemorrhagic and ischemic stroke 
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to differ according to some risk factors and outcome. 
Comorbidity has a significant impact on stroke out-
come!O Prognosis depends on the type of stroke, the 
degree and duration of obstruction or hemorrhage, 
and the extent of brain tissue death. The location 
of hemorrhagic stroke is an important factor in the 
outcome, and this type generally has a worse progno-
sis than ischemic stroke. The 30-day mortality from 
hemorrhagic stroke ranges from 35 to 52 percentll-15; 
one-half of these deaths occur within the first two 
days13.!'. Prognosis is generally poor when compared 
with ischemic stroke. Age, Glasgow Coma Score less 
than 8 at presentation, hematoma volume of greater 
than 60 mL, and intraventricular blood are predic-
tors of high mortality13, 17,18 . Considering risk factors, 
atherosclerosis was more frequently found in ischemic 
stroke patients because atherosclerotic plaques narrow 
the inner diameter of the vessel, resulting in inade-
quate tissue vascularization. 
Results of this hospital-based study confirmed 
that there was no sex difference in the type of stroke 
(P=0.7S3). 
Considering risk factors for ischemic stroke, there 
is a consensus in population and hospital-based stud-
ies that hypertension is the most common risk fac-
tor predisposing patients for all subtypes of ischemic 
stroke. Our study confirmed this statement. Results 
of previous hospital-based studies suggest that isch-
emic stroke is a polyetiologic disturbance with clear 
differences in the risk factor profile among particu-
lar ischemic stroke subtypes. According to previous 
investigations, the synergistic action of hypertension, 
diabetes and hyperlipidemia predisposes patients for 
lacunar stroke'. Of the known controllable risk fac-
tors, hypertension is most important19. Hypertension 
accelerates the atherosclerosis process, therebyincreas-
ing the risk of atherothrombotic cerebral infarction. It 
also increases the risk of cerebral hemorrhage in part 
by promoting the development of cerebral vascular 
micro aneurysms (Charcot-Bouchard aneurysms)20,21. 
Hemorrhagic and ischemic stroke differ according 
to outcome and risk factors. Atherosclerosis, atrial fi-
brillation and hyperlipidemia are the most powerful 
risk factors, which contribute to differences in mani-
festation of the resulting stroke type and outcome. 
These risk factors are by far more common in ischemic 
than in hemorrhagic stroke. 
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Ischemic stroke can be predisposed by excessive 
alcohol intake and by intracerebral and subarachnoid 
hemorrhage via multiple mechanisms (e.g., via hy-
pertension, atrial fibri11ation, rebound thrombocytosis 
and platelet aggregation and clotting disturbances)22. 
Our data confirmed the increased risk of primary 
intracerebral hemorrhage to be associated with low 
cholesterol, a relationship that may apply specifically 
to hemorrhages from hypertensive vasculopathy'3 
Since treatment measures for stroke are sti11 rather 
limited, and knowing the high number of patients 
suffering stroke every year, it is important to be famil-
iar with the stroke risk factor profile for each patient, 
and to be aware that prevention, i.e. timely identifica-
tion and therapy for stroke risk factors, is the most 
efficacious method of stroke treatment. The individu-
als with a relatively high risk profile can take steps 
to modify other risk factors through lifestyle changes 
and/or medical treatment. Similarly, public awareness 
programs aimed at increasing the recognition of stroke 
warning signs and altering modifiable risk factors can 
be designed to address the high-risk groups. 
Although this study did not produce any new or 
surprising results, the value of small hospital-based 
studies like this one lies in strengthening the aware-
ness of the important role of stroke prevention while 
influencing risk factors. Every person, not only health 
care professionals, can contribute to stroke prevention 
by promoting healthy lifestyle and avoiding known 
risk factors for stroke. 
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Saietak 
RAZLIKE U CIMBENICIMA RIZIKA I ISHODU IZMEDU ISHEMIJSKOG I HEMORAGIJSKOG 
MOZDANOG UDARA 
L Bilii, G. Dzamonja, L Lufit, M. MatiJaca i K. Caljkufit 
Cilj studije bio je provjeriti opravdanost hipoteze kako se cimbenici rizika ne razlikuju izmedu ishemijskog i hemora-
gijskog moidanog udara. Ova retrospektivna studija ukljucila je 1066 bolesnika s moidanim udarom. Ucestalost rizicnih 
cimbenika i bolnicko preiivljenje usporedeni su izmedu bolesnika s ishemijskim i hemoragijskim moidanim udarom. 
Podatci su izvedeni iz bolesniCkih kartona. Statisticka analiza je provedena pomocu x2-testa and t-testa za zavisne uzor-
ke. Skupina bolesnika s hemoragijskim moidanim udarom imala je 70 (47,9%) iena i 76 (52,1%) muskaraca, a skupina s 
ishemijskim moidanim udarom 450 (48,9%) iena i 470 (51,1%) muSkaraca. Bolesnici s ishemijskim moidanim udarom 
imali su vecu ucestalost hipertenzije (79010 prema 72%), aterosklerotske bolesti (50% prema 34%) i atrijske fibrilacije (15,5% 
prema 4,2%) i bili su statistiCki znaeajno stariji (72,5±1O,4 prema 65,7±12,8) od bolesnika s hemoragijskim moidanim 
udarom, ali je smrtni ishod bio cdCi kod ovih potonjih (26% prema 17%). Dakle, analiza prikupljenih podataka ukazala je 
na razlike izmedu hemoragijskog i ishemijskog moidanog udara u rizicnim cimbenicima i ishodu bolesti. 
Kljucne rijeci: Cerebrovaskularne bolesti - klasifikaciJa; Cerebrovaskularne bolesti - diJagnostika; Cerebrovaskularne bolesti -
rizicni Cimbenici; IncidenciJa; Dob - raspo4fela 
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